https://www.businesswire.com/news/home/20181107005049/en/

SOUTHLAKE, Texas--(BUSINESS WIRE)--Nov 7, 2018--HeartSciences, a medical device company developing next generation ECG devices using continuous wavelet transform (CWT) signal processing, is proud to announce its participation as an exhibitor at the upcoming 2018 Scientific Sessions of the American Heart Association (AHA). The AHA Congress will take place November 10-12, 2018 at the McCormick Place, Chicago, Illinois. HeartSciences will highlight its MyoVista® Wavelet ECG ( Device as well as recent clinical study results published in the Journal of the American College of Cardiology ( JACC ).

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181107005049/en/